Final Opinions
Triphenyl Phosphate: Final SCCS opinion
On 26 July 2024, the SCCS published the final opinion on the safety of Triphenyl Phosphate (CAS No.204-112-2, EC No.115-86-6).
On average, 70% of our news is listed, while updates from the last 30 days are not visible.
To get access to all content and services,
Start your Free Trial or Discover our plans.
Already a Premium member? Sign In
Requests For Opinions
Ethylhexyl Methoxycinnamate (EHMC): Request for SCCS Opinion
The Commission requests the SCCS to carry out a safety assessment on Ethylhexyl Methoxycinnamate (EHMC) (CAS No. 5466- 77-3/83834-59-7, EC No. 226-775-7/629-661-9). The Committee has nine months to deliver its Opinion.
European Commission
New hazard classes to the CLP Regulation
On 31 March 2023, the European Commission published the delegated act (Regulation (EU) 2023/707) amending Regulation (EC) No 1272/2008 as regards hazard classes and criteria for the classification, labelling, and packaging of substances and mixtures. The delegated act contains criteria for:
Preliminary Opinions
Salicylic Acid: Preliminary SCCS opinion
On 15 December 2022, the SCCS published the preliminary opinion on Salicylic Acid with CAS no “69-72-7”. The deadline for comments was set for 17 February 2023.
ECHA
Cosmetic ingredients in CoRAP for the years 2022-2024
ECHA has updated the list of the substances included in the Community rolling action plan (CoRAP) for the years 2022-2024. Interestingly, 9 out of 27 substances included in the CoRAP process, are authorized ingredients that can be used in cosmetic products, while one substance is prohibited in cosmetics.
Requests For Opinions
Salicylic Acid: Request for SCCS opinion
Considering the concerns related to potential endocrine-disrupting properties of “Salicylic Acid” the European Commission has asked the Scientific Committee to assess its safety in cosmetic products. On 3 February 2022, this mandate has been accepted by the SCCS and the Committee has nine months to deliver its Opinion.
Requests For Opinions
Butylparaben: Request for SCCS opinion
Considering the concerns related to potential endocrine disrupting properties of “Butylparaben”, the European Commission has asked the Scientific Committee to assess its safety as a preservative in cosmetic products. On 5 October 2021, this mandate has been accepted by the SCCS and the Committee has nine months to deliver its Read more…